321 related articles for article (PubMed ID: 25591906)
81. Psychosocial functioning, quality of life and clinical correlates of comorbid alcohol and drug dependence syndromes in people with schizophrenia across Europe.
Carrà G; Johnson S; Crocamo C; Angermeyer MC; Brugha T; Azorin JM; Toumi M; Bebbington PE
Psychiatry Res; 2016 May; 239():301-7. PubMed ID: 27046394
[TBL] [Abstract][Full Text] [Related]
82. Sudden death in psychiatric patients.
Ruschena D; Mullen PE; Burgess P; Cordner SM; Barry-Walsh J; Drummer OH; Palmer S; Browne C; Wallace C
Br J Psychiatry; 1998 Apr; 172():331-6. PubMed ID: 9715336
[TBL] [Abstract][Full Text] [Related]
83. Comorbid non-alcohol substance misuse among people with schizophrenia: epidemiological study in central London.
Duke PJ; Pantelis C; McPhillips MA; Barnes TR
Br J Psychiatry; 2001 Dec; 179():509-13. PubMed ID: 11731353
[TBL] [Abstract][Full Text] [Related]
84. Psychiatric factors affecting recovery after a long term treatment program for substance use disorder.
Daigre C; Perea-Ortueta M; Berenguer M; Esculies O; Sorribes-Puertas M; Palma-Alvarez R; Martínez-Luna N; Ramos-Quiroga JA; Grau-López L
Psychiatry Res; 2019 Jun; 276():283-289. PubMed ID: 31128488
[TBL] [Abstract][Full Text] [Related]
85. Rate of progression from first use to dependence on cocaine or opioids: a cross-substance examination of associated demographic, psychiatric, and childhood risk factors.
Sartor CE; Kranzler HR; Gelernter J
Addict Behav; 2014 Feb; 39(2):473-9. PubMed ID: 24238782
[TBL] [Abstract][Full Text] [Related]
86. Association of psychiatric and substance use disorder comorbidity with cocaine dependence severity and treatment utilization in cocaine-dependent individuals.
Ford JD; Gelernter J; DeVoe JS; Zhang W; Weiss RD; Brady K; Farrer L; Kranzler HR
Drug Alcohol Depend; 2009 Jan; 99(1-3):193-203. PubMed ID: 18775607
[TBL] [Abstract][Full Text] [Related]
87. Patient Characteristics Predicting Abstinence in Substance Use Disorder Patients With Comorbid Mental Disorders.
van Hagen LJ; de Waal MM; Christ C; Dekker JJM; Goudriaan AE
J Dual Diagn; 2019; 15(4):312-323. PubMed ID: 31566115
[No Abstract] [Full Text] [Related]
88. Comorbidity of mental disorders and alcohol- and drug-use disorders: analysis of New South Wales inpatient data.
Lai HM; Huang QR
Drug Alcohol Rev; 2009 May; 28(3):235-42. PubMed ID: 21462397
[TBL] [Abstract][Full Text] [Related]
89. Substance abuse and the risk of readmission of people with schizophrenia at Amanuel Psychiatric Hospital, Ethiopia.
Bimerew MS; Sonn FC; Kortenbout WP
Curationis; 2007 Jun; 30(2):74-81. PubMed ID: 17703825
[TBL] [Abstract][Full Text] [Related]
90. Prevalence and Risk of Violent Ideation and Behavior in Serious Mental Illnesses: An Analysis of 63,572 Patient Records.
Roché MW; Boyle DJ; Cheng CC; Del Pozzo J; Cherneski L; Pascarella J; Lukachko A; Silverstein SM
J Interpers Violence; 2021 Mar; 36(5-6):2732-2752. PubMed ID: 29534632
[TBL] [Abstract][Full Text] [Related]
91. Drug treatment outcomes for adolescents with comorbid mental and substance use disorders.
Grella CE; Hser YI; Joshi V; Rounds-Bryant J
J Nerv Ment Dis; 2001 Jun; 189(6):384-92. PubMed ID: 11434639
[TBL] [Abstract][Full Text] [Related]
92. Comorbid substance use disorders in schizophrenia: a latent class approach.
Kerner B
Psychiatry Res; 2015 Feb; 225(3):395-401. PubMed ID: 25576367
[TBL] [Abstract][Full Text] [Related]
93. The association of psychiatric comorbidity with treatment completion among clients admitted to substance use treatment programs in a U.S. national sample.
Krawczyk N; Feder KA; Saloner B; Crum RM; Kealhofer M; Mojtabai R
Drug Alcohol Depend; 2017 Jun; 175():157-163. PubMed ID: 28432939
[TBL] [Abstract][Full Text] [Related]
94. Diagnostic subgroups within a sample of comorbid substance abusers: correlates and characteristics.
Toneatto T; Negrete JC; Calderwood K
Am J Addict; 2000; 9(3):253-64. PubMed ID: 11000921
[TBL] [Abstract][Full Text] [Related]
95. Treatment of substance abusing patients with comorbid psychiatric disorders.
Kelly TM; Daley DC; Douaihy AB
Addict Behav; 2012 Jan; 37(1):11-24. PubMed ID: 21981788
[TBL] [Abstract][Full Text] [Related]
96. Impact of substance use and other risk factor exposures on conviction rates by people with a psychotic illness and other mental disorders.
Valuri GM; Morgan F; Jablensky A; Ambrosi TL; Morgan VA
Soc Psychiatry Psychiatr Epidemiol; 2020 Apr; 55(4):517-525. PubMed ID: 31324961
[TBL] [Abstract][Full Text] [Related]
97. Diabetes self-care behaviours among people diagnosed with serious mental illness: A cross-sectional correlational study.
Tzeng WC; Tai YM; Feng HP; Lin CH; Chang YC
J Psychiatr Ment Health Nurs; 2024 Jun; 31(3):364-375. PubMed ID: 37902110
[TBL] [Abstract][Full Text] [Related]
98. Substance dependence and remission in schizophrenia: A comparison of schizophrenia and affective disorders.
Bennett ME; Bellack AS; Brown CH; DiClemente C
Addict Behav; 2009 Oct; 34(10):806-14. PubMed ID: 19375237
[TBL] [Abstract][Full Text] [Related]
99. Issues in treating patients with combined substance abuse and Axes I AND II general psychiatric disorders.
Paizis M; Ross S; Dermatis H
Subst Abus; 2005 Mar; 26(1):43-4. PubMed ID: 16492662
[No Abstract] [Full Text] [Related]
100. The temporal association between suicide and comorbid mental disorders in people treated for substance use disorders: a National registry study.
Myhre MØ; Walby FA; Bramness JG; Mehlum L
Addict Sci Clin Pract; 2023 Oct; 18(1):59. PubMed ID: 37821976
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
